--2025/Q4-- / 6.770M--
--2025/Q3-- / 6.585M--
Dec 10, 20242025/Q26.125M / 6.439M--
Sep 16, 20242025/Q15.263M / 6.750M--
Jul 29, 20242024/Q46.459M / 6.530M--
US Stock MarketDetailed Quotes
IPA ImmunoPrecise Antibodies
- 0.400
- -0.020-4.76%
Close Dec 20 16:00 ET
- 0.410
- +0.010+2.42%
Post 16:55 ET
12.43MMarket Cap-0.54P/E (TTM)
0.440High0.399Low192.81KVolume0.418Open0.420Pre Close78.98KTurnover0.72%Turnover RatioLossP/E (Static)31.06MShares2.60052wk High0.55P/B10.73MFloat Cap0.32552wk Low--Dividend TTM26.81MShs Float33.340Historical High--Div YieldTTM9.81%Amplitude0.325Historical Low0.409Avg Price1Lot Size
ImmunoPrecise Antibodies Key Stats
ImmunoPrecise Antibodies Q2 2025 Earnings Date
Currency：CADDec 10, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 6.44M | 6.13M | -314.00K |
| Miss Est. | +4.70% | -0.41% | -4.88% |
| EPS | -0.10 | -0.09 | +<0.01 |
| Beat Est. | +5.19% | +10.00% | +7.02% |
Analyst Rating
Dec 22, 2024
ImmunoPrecise Antibodies Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
ImmunoPrecise Antibodies Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data